Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119248) titled 'A Real-World Study on the Effects of Lemborexant on Sleep and Cognitive Function in Elderly Patients with Mental Disorders Complicated by Insomnia' on Feb. 25.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Huilongguan Hospital Affiliated to Capital Medical University
Condition:
late-life depressive disorder, Alzheimer's disease dementia, schizophrenia, bipolar disorder
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-01-06
Target Sample Size: Lemborexant Treatment Group:250;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...